AIHealthcare

Turbine, also branded Turbine AI, is a biotechnology and virtual-biology company that uses artificial intelligence, machine learning, and biological modeling to virtualize experiments for biopharmaceutical research. Its core Simulated Cell and Virtual Lab platforms model cellular signaling and treatment responses, enabling in-silico experiments for oncology and, increasingly, immunology. The company positions its technology as a lab-in-the-loop platform for target discovery, biomarker selection, drug-combination design, antibody-drug-conjugate research, clinical positioning, and translational medicine. Turbine’s market position is that of a B2B AI drug-discovery and computational-biology platform serving pharmaceutical and biotechnology companies, with reported collaborations or partnerships involving Bayer, AstraZeneca, Merck & Co., and other major pharmaceutical companies.